Digital health startup Human Health has secured $8.5 million in funding to expand its platform internationally, enhance product intelligence, and scale patient-driven research.
Founded in 2021 by former Canva product leaders Georgia Vidler and Kate Lambridis, the company aims to give patients with chronic conditions greater control over their healthcare journeys. The raise follows a $10.15 million seed round in 2022, which at the time was the largest seed investment for an all-female founder team.
Human Health provides a platform that enables patients to track symptoms, monitor treatments, and generate personalised insights that can be shared with clinicians.
Long-term, and with patient consent, the company plans to aggregate anonymised health data to support research and accelerate the development of diagnostics and therapies.
The new funding will support deeper product focus in areas such as women’s health, respiratory conditions, pain management, and autoimmune diseases.
The company claims to address critical gaps in healthcare systems, where chronic illness management often falls short. In the United States, roughly 75% of adults live with at least one chronic condition; in Australia, over 50% manage long-term illness; and in the United Kingdom, nearly half of adults report persistent health issues.
Human Health’s platform aims to reduce inefficiencies by consolidating patient data into actionable insights, potentially easing strain on overburdened healthcare providers.
Co-founder Kate Lambridis drew inspiration from her personal experiences: tracking her son’s chronic illness enabled her to advocate for treatment and contribute data that now informs research.
“Right now, too many people are left in limbo; stuck on waiting lists, repeating their stories to different doctors, and trying to make sense of complex conditions without the right tools,” Lambridis said.
The round included participation from LocalGlobe, Airtree, Skip Capital, all-female venture fund Aliavia, and Scale Ventures. Julia Hawkins, general partner at LocalGlobe, described the investment as a way to “empower individuals to make sense of their own health data in order to enable truly personalised care.”
Human Health reports more than 200,000 registered users who have logged over 20 million health actions globally, with daily activity exceeding 40,000 actions.
The company is also developing Human Evidence, a platform designed to give researchers access to real-world patient data directly contributed by users, which could facilitate observational studies and accelerate clinical research.
